Will This ETF Beat the Market Over the Next 12 Months?
2024 was another banner year for the US stock market,…
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | $647.3K | $824.5K | $2M | $264.6K | |
Gross Profit | -- | -$647.3K | -$824.5K | -$2M | -$264.6K | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $14.7M | $19.6M | $31.5M | $35.2M | |
Other Inc / (Exp) | -- | $1.3K | -- | -$3.3M | $28.4M | |
Operating Expenses | -- | $30.7M | $54.9M | $77.1M | $37M | |
Operating Income | -- | -$31.3M | -$55.8M | -$79.1M | -$37.3M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -$32.4M | -$59.1M | -$88.1M | -$5.3M | |
Earnings of Discontinued Ops. | -- | -$1.4M | $152.9K | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -$33.8M | -$58.9M | -$88.1M | -$5.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$33.8M | -$58.9M | -$88.1M | -$5.3M | |
Basic EPS (Cont. Ops) | -- | -$0.25 | -$0.41 | -$0.62 | -$0.03 | |
Diluted EPS (Cont. Ops) | -- | -$0.25 | -$0.41 | -$0.62 | -$0.03 | |
Weighted Average Basic Share | -- | $133.7M | $142.9M | $142.9M | $160.4M | |
Weighted Average Diluted Share | -- | $133.7M | $142.9M | $142.9M | $160.4M | |
EBITDA | -- | -$30.7M | -$55.3M | -$81.4M | -$4.6M | |
EBIT | -- | -$31.3M | -$56.1M | -$83.4M | -$4.9M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -$31.3M | -$55.8M | -$79.1M | -$37.3M | |
Operating Income (Adjusted) | -- | -$31.3M | -$56.1M | -$83.4M | -$4.9M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | $727.8K | $77.8K | $106.4K | |
Gross Profit | -- | -- | -$727.8K | -$77.8K | -$106.4K | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | $6.5M | $4.2M | $7.6M | |
Other Inc / (Exp) | -- | -- | $952.1K | $4.1M | -$10M | |
Operating Expenses | -- | -- | $14.6M | $4.2M | $7.6M | |
Operating Income | -- | -- | -$15.4M | -$4.3M | -$7.8M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -$15.8M | -$268.4K | -$11M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -$288.6K | -$11M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -$15.8M | -$268.4K | -$11M | |
Basic EPS (Cont. Ops) | -- | -- | -$0.11 | -$0.00 | -$0.05 | |
Diluted EPS (Cont. Ops) | -- | -- | -$0.11 | -$0.00 | -$0.05 | |
Weighted Average Basic Share | -- | -- | $142.9M | $160M | $218M | |
Weighted Average Diluted Share | -- | -- | $142.9M | $160M | $218M | |
EBITDA | -- | -- | -$14.4M | -$268.4K | -$10.9M | |
EBIT | -- | -- | -$14.4M | -$268.4K | -$11M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -$15.4M | -$4.3M | -$7.8M | |
Operating Income (Adjusted) | -- | -- | -$14.4M | -$268.4K | -$11M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | $27.1M | $42.1M | |
Other Inc / (Exp) | -- | -- | $952.1K | $32.5M | -$22M | |
Operating Expenses | -- | -- | -- | $49.5M | $42.4M | |
Operating Income | -- | -- | -- | -$49.9M | -$42.4M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -$19.8M | -$45.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -$45.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -$19.8M | -$45.2M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -$0.15 | -$0.26 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.15 | -$0.26 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -$39.4M | -$45M | |
EBIT | -- | -- | -- | -$40M | -$45.3M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -$49.9M | -$42.4M | |
Operating Income (Adjusted) | -- | -- | -- | -$40M | -$45.3M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | $949.4K | $154.5K | $214.5K | |
Gross Profit | -- | -- | -$949.4K | -$154.5K | -$214.5K | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | $11.7M | $13.4M | $23.4M | |
Other Inc / (Exp) | -- | -- | $952.1K | $31.2M | -$19.1M | |
Operating Expenses | -- | -- | $28.9M | $18.5M | $23.4M | |
Operating Income | -- | -- | -$29.9M | -$18.7M | -$23.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -$31.4M | $12M | -$27.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -$15.7M | $12M | -$27.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -$31.4M | $12M | -$27.7M | |
Basic EPS (Cont. Ops) | -- | -- | -$0.22 | $0.07 | -$0.15 | |
Diluted EPS (Cont. Ops) | -- | -- | -$0.22 | $0.07 | -$0.15 | |
Weighted Average Basic Share | -- | -- | $285.7M | $462.9M | $584.5M | |
Weighted Average Diluted Share | -- | -- | $285.7M | $462.9M | $584.5M | |
EBITDA | -- | -- | -$28.4M | -$8.7M | -$27.4M | |
EBIT | -- | -- | -$28.8M | -$9M | -$27.7M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -$29.9M | -$18.7M | -$23.6M | |
Operating Income (Adjusted) | -- | -- | -$28.8M | -$9M | -$27.7M |
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | $1.2M | $862.8K | $259.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | $158K | $4.1K | $3.9M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | $960.9K | $1.8M | $7.8M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | -- | $2.3M | $2.6M | $273M | |
Property Plant And Equipment | -- | -- | $11.5M | $18.2M | $294.6M | |
Long-Term Investments | -- | -- | -- | $16.9M | $14.8M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | $381.9K | |
Total Assets | -- | -- | $13.8M | $37.8M | $582.8M | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | $59.1M | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | $386.2K | $982.2K | $1.6M | |
Total Current Liabilities | -- | -- | $5.8M | $73.5M | $32.6M | |
Long-Term Debt | -- | -- | $51M | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | $67M | $84.5M | $42.5M | |
Common Stock | -- | -- | -- | -- | $871M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -$53.1M | -$46.7M | $540.3M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -$53.1M | -$46.7M | $540.3M | |
Total Liabilities and Equity | -- | -- | $13.8M | $37.8M | $582.8M | |
Cash and Short Terms | -- | -- | $1.2M | $862.8K | $259.3M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | -- | $272.4M | $460.9M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | $57.1K | $204K | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | $22.9M | $7.7M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | -- | -- | $297M | $471.5M | |
Property Plant And Equipment | -- | -- | -- | $180.4M | $457.1M | |
Long-Term Investments | -- | -- | -- | $16.5M | $7.1M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | $389.1K | |
Total Assets | -- | -- | -- | $493.9M | $936.1M | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | $62.9M | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $1.7M | |
Other Current Liabilities | -- | -- | -- | $1.6M | $283.7K | |
Total Current Liabilities | -- | -- | -- | $87.8M | $34M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | -- | $94.9M | $46.3M | |
Common Stock | -- | -- | -- | $740.7M | $1.3B | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -- | $399.1M | $889.8M | |
Total Liabilities and Equity | -- | -- | -- | $493.9M | $936.1M | |
Cash and Short Terms | $96.2M | $614.9M | $536.3M | $272.4M | $460.9M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$33.8M | -$58.9M | -$88.1M | -$5.3M | |
Depreciation & Amoritzation | -- | $647.3K | $824.5K | $2M | $264.6K | |
Stock-Based Compensation | -- | $2.2M | $2.3M | $3.1M | $7.5M | |
Change in Accounts Receivable | -- | $234.5K | -$657.9K | -$549.5K | -$6.6M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -$27.1M | -$53.8M | -$67.5M | -$51.2M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$885.8K | $2.8M | -$26.8M | -$256.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $18.1M | $29.5M | -- | $432.1M | |
Long-Term Debt Repaid | -- | -- | -$329.6K | -$485.8K | -$23.9M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $10M | $953.6K | -- | $101.2M | |
Cash From Financing | -- | $28.4M | $51.5M | $94M | $570.9M | |
Beginning Cash (CF) | -- | $292.2K | $641.6K | $1.2M | $858.5K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | $394K | $527.6K | -$385.8K | $263M | |
Ending Cash (CF) | -- | $686.1K | $1.2M | $826.2K | $263.9M | |
Levered Free Cash Flow | -- | -$28M | -$56.2M | -$74.8M | -$307.5M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$288.6K | -$11M | |
Depreciation & Amoritzation | -- | -- | -- | -$430 | $106.1K | |
Stock-Based Compensation | -- | -- | -- | -$210 | $1.7M | |
Change in Accounts Receivable | -- | -- | -- | -$1M | $2.2M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -$8.7M | $941.6K | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -$79.4M | -$47.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -$704.7K | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$252.9K | -$400.6K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -$1.6M | -$9.8K | |
Cash From Financing | -- | -- | -- | $5.3M | -$1.5M | |
Beginning Cash (CF) | -- | -- | -- | $351.9M | $514.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -$82.9M | -$48M | |
Ending Cash (CF) | -- | -- | -- | $269.1M | $465.5M | |
Levered Free Cash Flow | -- | -- | -- | -$88.1M | -$46.5M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -$45.1M | |
Depreciation & Amoritzation | -- | -- | -- | -- | $226.7K | |
Stock-Based Compensation | -- | -- | $379.9K | $130.2K | $12.7M | |
Change in Accounts Receivable | -- | -- | -- | -- | -$3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$37.2M | -$56M | -$86.8M | -- | -$10.6M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -$254.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | $2.5M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$3.7M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | $458.7M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | $193.6M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -$217.3M | -$264.8M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -$15.7M | $12M | -$27.8M | |
Depreciation & Amoritzation | -- | -- | $401.4K | $263K | $225.1K | |
Stock-Based Compensation | -- | -- | $379.9K | $130.2K | $5.3M | |
Change in Accounts Receivable | -- | -- | -$1.5M | $1.7M | $5.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -$15.8M | -$45.3M | -$4.7M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -$829.4K | -$155.3M | -$153.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $429.6M | -- | |
Long-Term Debt Repaid | -- | -- | -$78.5K | -$21.2M | -$1M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -$1.6M | -$17.5M | |
Cash From Financing | -- | -- | $18.3M | $468.8M | $356.6M | |
Beginning Cash (CF) | -- | -- | $1.2M | $770.2M | $976.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | $1.6M | $268.2M | $198.7M | |
Ending Cash (CF) | -- | -- | $2.8M | $1B | $1.2B | |
Levered Free Cash Flow | -- | -- | -$16.7M | -$200.6M | -$157.9M |
Signup to receive the latest stock alerts
2024 was another banner year for the US stock market,…
Carlos Slim made a splash in a surprising sector last…
There is a lot of humdrum in the market about…
Market Cap: $3.7T
P/E Ratio: 40x
Market Cap: $3.4T
P/E Ratio: 116x
Market Cap: $3.1T
P/E Ratio: 35x
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Banco Macro SA [BMA] is up 0.88% over the past day.
Agrify [AGFY] is down 5.86% over the past day.